ScholarIQanswers from OpenAlex
Institut Bergonié
InstitutionResearch output, impact & collaborations
Institut Bergonié is a institution indexed in ScholarIQ from OpenAlex.
What is known about Institut Bergonié?
ScholarIQrecord summary
Institut Bergonié is a research organisation in Bordeaux, FR. OpenAlex records 8,185 works and 685,499 citations for it. 1,425 researchers list it as their most recent affiliation.
How many works does Institut Bergonié have?
ScholarIQindexed works
Institut Bergonié has 8,185 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Institut Bergonié have?
ScholarIQcitation count
Institut Bergonié has 685,499 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Institut Bergonié?
ScholarIQresearcher count
Institut Bergonié has 1,425 researchers in the ScholarIQ index.
What is the average h-index at Institut Bergonié?
ScholarIQavg h-index
Institut Bergonié has an average h-index of 61 in OpenAlex.
What is the ROR of Institut Bergonié?
ScholarIQror
The ROR for Institut Bergonié is on the source record.
What is the OpenAlex record for Institut Bergonié?
ScholarIQopenalex
The OpenAlex for Institut Bergonié is on the source record.
Who are the most-cited researchers behind Institut Bergonié?
ScholarIQtop researchers by citations
What are the most-cited papers on Institut Bergonié?
ScholarIQmost cited works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Susanne Saußele, Johan Richter, Joëlle Guilhot, Franz Gruber, Henrik Hjorth-Hansen, António Almeida, Jeroen J. W. M. Janssen, Jiřı́ Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson‐Strömberg, Joaquín Martínez‐López, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Kateřina Machová Poláková, Martin C. Müller, Satu Mustjoki, Marc Berger, Alice Fabarius, Wolf‐Karsten Hofmann, Andreas Hochhaus, Markus Pfirrmann, François‐Xavier Mahon, Gert J. Ossenkoppele, Maria Pagoni, Stina Söderlund, Martine Escoffre‐Barbe, Gabriel Étienne, Jolanta Dengler, Françoise Huguet, Nikolas von Bubnoff, Hana Klamová, Edgar Faber, François Guilhot, Kourosh Lotfi, Delphine Réa, Tim H. Brümmendorf, G.E. de Greef, Leif Stenke, Franck E. Nicolini, Laurence Legros, Andreas Burchert, J Voglová, Aude Charbonnier, Emmanuel Gyan, Volker Kunzmann, Peter E. Westerweel
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
T D Kim, Delphine Réa, Michaela Schwarz, Peggy Grille, Franck E. Nicolini, Gianantonio Rosti, Luciano Levato, Francis J. Giles, Hervé Dombret, Tristan Mirault, Hélène Labussière, Ruhdja Lindhorst, Wilhelm Haverkamp, Ivo Buschmann, Bernd Dörken, Phillipp D. Le Coutre
How much of the research on Institut Bergonié is open access?
ScholarIQopen access share
67%OPEN ACCESS